TY - JOUR
T1 - Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention
T2 - Insights from the VA CART Program
AU - Jovin, Ion S.
AU - Warsavage, Theodore J.
AU - Plomondon, Mary E.
AU - Grunwald, Gary K.
AU - Waldo, Stephen W.
AU - Rao, Sunil V.
AU - Brilakis, Emmanouil S.
AU - Azzalini, Lorenzo
N1 - Funding Information:
Dr. Ion S. Jovin is a consultant for GE Healthcare. Dr. Stephen W. Waldo has received unrelated investigator‐initiated research support from Abiomed, Cardiovascular Systems Incorporated, Janssen Pharmaceuticals, National Institutes of Health, and VA Health Services Research and Development. Dr. Emmanouil S. Brilakis has received consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor ), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Elsevier, GE Healthcare, IMDS, InfraRedx, Medicure, Medtronic, Opsens, Siemens, and Teleflex; owner, Hippocrates LLC; shareholder: MHI Ventures, Cleerly Health. Dr. Lorenzo Azzalini received honoraria from Teleflex, Abiomed, Abbott Vascular, Philips, Asahi Intecc, and Cardiovascular Systems Inc. The views expressed in this article are the views of the authors and do not necessarily represent the position or policy of the Department of Veterans Affairs or the United States Government. Other authors declare no conflicts of interest. Circulation
Funding Information:
This study was supported by an investigator‐initiated grant from GE Healthcare to Dr. Ion S. Jovin.
Publisher Copyright:
© 2022 Wiley Periodicals LLC.
PY - 2022
Y1 - 2022
N2 - Objectives: To assess whether contrast media type is associated with outcomes in veterans undergoing percutaneous coronary intervention (PCI). Background: There is uncertainty about the impact of iso-osmolar contrast medium (IOCM) versus low-osmolar contrast medium (LOCM) on acute kidney injury (AKI) and other major adverse renal or cardiovascular events (MARCE) after PCI. We assessed the association between contrast media type and MARCE in patients who underwent PCI within the Veterans Administration Healthcare System. Methods: We reviewed PCIs performed between 2009 and 2019 using data from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. The primary endpoint was MARCE, a composite of myocardial infarction, stroke, all-cause death, AKI, and dialysis onset at 30 days. Results: The analysis cohort consisted of 50,389 patients of whom 25,555 received LOCM and 24,834 received IOCM. There was significant variation in contrast type across sites. After adjustment for comorbidities, no significant association between contrast media type and MARCE was observed in both site—unadjusted (odds ratio [OR] for IOCM: 0.99; 95% confidence interval [CI]: 0.92–1.08; p = 0.97) and site-adjusted (OR: 1.06; 95% CI: 0.95–1.18; p = 0.30) analyses. Similar results were obtained when contrast volume was imputed or the data was subset to individuals with available contrast volume. Conclusion: In a large cohort of veterans undergoing PCI, we found considerable site variation in the type of contrast media used but no significant association between contrast media type and the incidence of MARCE, both before and after adjustment for the site.
AB - Objectives: To assess whether contrast media type is associated with outcomes in veterans undergoing percutaneous coronary intervention (PCI). Background: There is uncertainty about the impact of iso-osmolar contrast medium (IOCM) versus low-osmolar contrast medium (LOCM) on acute kidney injury (AKI) and other major adverse renal or cardiovascular events (MARCE) after PCI. We assessed the association between contrast media type and MARCE in patients who underwent PCI within the Veterans Administration Healthcare System. Methods: We reviewed PCIs performed between 2009 and 2019 using data from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. The primary endpoint was MARCE, a composite of myocardial infarction, stroke, all-cause death, AKI, and dialysis onset at 30 days. Results: The analysis cohort consisted of 50,389 patients of whom 25,555 received LOCM and 24,834 received IOCM. There was significant variation in contrast type across sites. After adjustment for comorbidities, no significant association between contrast media type and MARCE was observed in both site—unadjusted (odds ratio [OR] for IOCM: 0.99; 95% confidence interval [CI]: 0.92–1.08; p = 0.97) and site-adjusted (OR: 1.06; 95% CI: 0.95–1.18; p = 0.30) analyses. Similar results were obtained when contrast volume was imputed or the data was subset to individuals with available contrast volume. Conclusion: In a large cohort of veterans undergoing PCI, we found considerable site variation in the type of contrast media used but no significant association between contrast media type and the incidence of MARCE, both before and after adjustment for the site.
KW - acute kidney injury
KW - contrast
KW - outcomes
KW - percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=85129789882&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129789882&partnerID=8YFLogxK
U2 - 10.1002/ccd.30218
DO - 10.1002/ccd.30218
M3 - Article
C2 - 35500170
AN - SCOPUS:85129789882
SN - 1522-1946
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
ER -